Fulcrum Therapeutics, Inc.

FULC

$3.52

Name : Fulcrum Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $234,549,280.00

EPSttm : -1.15

Fulcrum Therapeutics, Inc.

$3.52

2.33%

$0.08

FULC — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

13.82

Margin Of Safety %

Put/Call OI Ratio

0.37

EPS Next Q Diff

0.07

EPS Last/This Y

0.36

EPS This/Next Y

0.2

Price

3.51

Target Price

Analyst Recom

3.33

Performance Q

-56.05

Upside

-818.7%

Beta

3.04

Ticker: FULC

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	FULC	6.99	0.27	10.50	12886
2026-05-12	FULC	6.95	0.27	0.40	12903
2026-05-13	FULC	7.25	0.27	2.00	12918
2026-05-14	FULC	7.09	0.27	56.00	12920
2026-05-15	FULC	6.7	0.27	999.99	12920
2026-05-18	FULC	6.08	0.18	0.04	11149
2026-05-19	FULC	5.91	0.17	2.10	11707
2026-05-20	FULC	6.34	0.19	0.00	11885
2026-05-21	FULC	6.59	0.19	0.00	11885
2026-05-22	FULC	6.56	0.19	0.05	11885
2026-05-26	FULC	6.75	0.19	0.00	12011
2026-05-27	FULC	6.77	0.19	0.16	12013
2026-05-28	FULC	6.82	0.19	2.00	12156
2026-05-29	FULC	6.93	0.19	999.99	12160
2026-06-02	FULC	3.13	0.16	0.60	11849
2026-06-03	FULC	3.19	0.34	0.43	25629
2026-06-04	FULC	3.36	0.34	2.65	26135
2026-06-05	FULC	3.68	0.35	0.03	26321
2026-06-08	FULC	3.45	0.33	2.97	27131
2026-06-09	FULC	3.51	0.37	5.24	27861
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	FULC	7.00	-2.1	-	-1.19
2026-05-12	FULC	6.95	-2.1	-	-1.19
2026-05-13	FULC	7.26	-2.1	-	-1.19
2026-05-14	FULC	7.09	-2.1	-	-1.19
2026-05-15	FULC	6.69	-2.1	-	-1.17
2026-05-18	FULC	6.09	-0.5	-	-1.17
2026-05-19	FULC	5.91	-0.5	-	-1.17
2026-05-20	FULC	6.35	-0.5	-	-1.17
2026-05-21	FULC	6.61	-0.5	-	-1.17
2026-05-22	FULC	6.57	-0.5	-	-1.17
2026-05-26	FULC	6.76	-0.5	-	-1.17
2026-05-27	FULC	6.77	-0.5	-	-1.17
2026-05-28	FULC	6.82	-0.5	-	-1.17
2026-05-29	FULC	6.93	-0.5	-	-1.17
2026-06-01	FULC	6.40	-0.5	-	-1.17
2026-06-02	FULC	3.14	-0.5	-	-1.17
2026-06-03	FULC	3.20	-0.5	-	-1.17
2026-06-04	FULC	3.37	-0.5	-	-1.17
2026-06-05	FULC	3.68	-0.5	-	-1.17
2026-06-08	FULC	3.44	16.6	-	-0.82
2026-06-09	FULC	3.51	16.6	-	-0.82
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	FULC	-30.11	29.35	13.29
2026-05-12	FULC	-30.11	29.35	14.02
2026-05-13	FULC	-30.11	29.35	14.02
2026-05-14	FULC	-30.11	29.35	14.02
2026-05-15	FULC	-30.11	29.35	14.02
2026-05-18	FULC	-30.11	28.19	14.12
2026-05-19	FULC	-29.27	28.19	14.12
2026-05-20	FULC	-29.27	28.19	14.12
2026-05-21	FULC	-29.27	28.19	14.12
2026-05-22	FULC	-29.19	28.19	14.12
2026-05-26	FULC	-29.19	6.98	14.12
2026-05-27	FULC	-29.19	6.98	14.12
2026-05-28	FULC	-29.19	6.98	13.82
2026-05-29	FULC	-29.19	6.98	13.82
2026-06-02	FULC	-29.19	6.42	13.82
2026-06-03	FULC	-29.19	6.42	13.82
2026-06-04	FULC	-29.19	6.42	13.82
2026-06-05	FULC	-29.19	6.42	13.82
2026-06-08	FULC	-29.18	6.62	13.82
2026-06-09	FULC	-29.18	6.62	13.82
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.25

Avg. EPS Est. Current Quarter

-0.23

Avg. EPS Est. Next Quarter

-0.18

Insider Transactions

-29.18

Institutional Transactions

6.62

Beta

3.04

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

89.4

Max Drawdown 5-Year %

-92.7

Target Price

P/E

Forward P/E

PEG

P/S

P/B

0.7

P/Free Cash Flow

EPS

-1.15

Average EPS Est. Cur. Y

-0.82

EPS Next Y. (Est.)

-0.61

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

2.44

Return on Equity vs Sector %

-50.3

Return on Equity vs Industry %

-34.2

EPS 1 7Days Diff

0.4

EPS 1 30Days Diff

0.38

EBIT Estimation

◆ FULC Healthcare

$3.52

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

11/25

Volume

0/15

Valuation

12/20

TP/AR

0/10

Options

7/10

RSI

26.7

Range 1M

14.8%

Sup Dist

5.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

15/30

Estimates

0/20

Inst/Vol

8/15

Options

5/10

EPS Yr

31.3%

EPS NY

12.8%

52W%

5.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +42% upside

Quality

2/30

Valuation

12/30

Growth

16/25

Stability

9/10

LT Trend

1/5

Upside

+42%

Quality

Fulcrum Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 55

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers programs for the treatment of diamond-blackfan anemia, Bone Marrow Failure Syndromes, novel fetal hemoglobin inducers, fibrotic disorders. It has licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

FULC

Latest News

—

Caricamento notizie per FULC…

stock quote shares FULC – Fulcrum Therapeutics Inc Stock Price stock today

news today FULC – Fulcrum Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch FULC – Fulcrum Therapeutics Inc yahoo finance google finance

stock history FULC – Fulcrum Therapeutics Inc invest stock market

stock prices FULC premarket after hours

ticker FULC fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: FULC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y